Literature DB >> 8985378

Characterization of the ion channels formed by poliovirus in planar lipid membranes.

M T Tosteson1, M Chow.   

Abstract

The steps in poliovirus infection leading to viral entry and uncoating are not well understood. Current evidence suggests that the virus first binds to a plasma membrane-bound receptor present in viable cells, leading to a conformational rearrangement of the viral proteins such that the virus crosses the membrane and releases the genomic RNA. The studies described in this report were undertaken to determine if poliovirus (160S) as well as one of the subviral particles (135S) could interact with membranes lacking poliovirus receptors in an effort to begin to understand the process of uncoating of the virus. We report that both forms of viral particles, 160S and 135S, interact with lipid membranes and induce the formation of ion-permeable channels in a manner that does not require acid pH. The channels induced by the viral particles 160S have a voltage-dependent conductance which depends on the ionic composition of the medium. Our findings raise the possibility that viral entry into cells may be mediated by direct interaction of viral surface proteins with membrane lipids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985378      PMCID: PMC191079     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Compartmentalization of subviral particles during poliovirus eclipse in HeLa cells.

Authors:  P Kronenberger; R Vrijsen; A Boeyé
Journal:  J Gen Virol       Date:  1992-07       Impact factor: 3.891

2.  Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.

Authors:  N Moscufo; M Chow
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  The adsorption and early fate of purified poliovirus in HeLa cells.

Authors:  W K JOKLIK; J E DARNELL
Journal:  Virology       Date:  1961-04       Impact factor: 3.616

4.  Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.

Authors:  C E Fricks; J M Hogle
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

5.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

6.  Cation content in poliovirus-infected HeLa cells.

Authors:  A López-Rivas; J L Castrillo; L Carrasco
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

7.  Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.

Authors:  Q Li; A G Yafal; Y M Lee; J Hogle; M Chow
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  The poliovirus 135S particle is infectious.

Authors:  S Curry; M Chow; J M Hogle
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  Reconstitution of the influenza virus M2 ion channel in lipid bilayers.

Authors:  M T Tosteson; L H Pinto; L J Holsinger; R A Lamb
Journal:  J Membr Biol       Date:  1994-10       Impact factor: 1.843

10.  Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.

Authors:  E Colston; V R Racaniello
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

View more
  41 in total

1.  Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus.

Authors:  D M Belnap; D J Filman; B L Trus; N Cheng; F P Booy; J F Conway; S Curry; C N Hiremath; S K Tsang; A C Steven; J M Hogle
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 2.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

3.  Genome delivery and ion channel properties are altered in VP4 mutants of poliovirus.

Authors:  Pranav Danthi; Magdalena Tosteson; Qi-Han Li; Marie Chow
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus.

Authors:  Amy L Odegard; Kartik Chandran; Xing Zhang; John S L Parker; Timothy S Baker; Max L Nibert
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  Picornaviruses.

Authors:  Tobias J Tuthill; Elisabetta Groppelli; James M Hogle; David J Rowlands
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

6.  Functional genetic and biophysical analyses of membrane disruption by human adenovirus.

Authors:  Crystal L Moyer; Christopher M Wiethoff; Oana Maier; Jason G Smith; Glen R Nemerow
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

7.  A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes.

Authors:  Nadine Kämper; Patricia M Day; Thorsten Nowak; Hans-Christoph Selinka; Luise Florin; Jan Bolscher; Lydia Hilbig; John T Schiller; Martin Sapp
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Cryo-electron microscopy reconstruction of a poliovirus-receptor-membrane complex.

Authors:  Doryen Bubeck; David J Filman; James M Hogle
Journal:  Nat Struct Mol Biol       Date:  2005-06-19       Impact factor: 15.369

9.  Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane.

Authors:  Melina A Agosto; Tijana Ivanovic; Max L Nibert
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

10.  Morphological changes in the T=3 capsid of Flock House virus during cell entry.

Authors:  Hanna E Walukiewicz; John E Johnson; Anette Schneemann
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.